Found: 115
Select item for more details and to access through your institution.
Characteristics and outcomes of patients with relapsed Philadelphia chromosome‐positive acute lymphoblastic leukemia after failure of a frontline ponatinib‐containing therapy.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1423, doi. 10.1002/ajh.27329
- By:
- Publication type:
- Article
Safety and long‐term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single‐center phase 1,2 trial.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 836, doi. 10.1002/ajh.27254
- By:
- Publication type:
- Article
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 562, doi. 10.1002/ajh.27233
- By:
- Publication type:
- Article
Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. 38, doi. 10.1002/ajh.27126
- By:
- Publication type:
- Article
Single‐agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1571, doi. 10.1002/ajh.27029
- By:
- Publication type:
- Article
Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT‐PCR for BCR::ABL1.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1196, doi. 10.1002/ajh.26949
- By:
- Publication type:
- Article
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B‐cell acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 6, p. E142, doi. 10.1002/ajh.26907
- By:
- Publication type:
- Article
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. 712, doi. 10.1002/ajh.26870
- By:
- Publication type:
- Article
Frontline combination of ponatinib and hyper‐CVAD in Philadelphia chromosome‐positive acute lymphoblastic leukemia: 80‐months follow‐up results.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 493, doi. 10.1002/ajh.26816
- By:
- Publication type:
- Article
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E35, doi. 10.1002/ajh.26789
- By:
- Publication type:
- Article
Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. E201, doi. 10.1002/ajh.26526
- By:
- Publication type:
- Article
External validation of the HIGH‐2‐LOW model: A predictive score for venous thromboembolism after allogeneic transplant.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 740, doi. 10.1002/ajh.26521
- By:
- Publication type:
- Article
Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity‐score matched analysis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. E455, doi. 10.1002/ajh.26360
- By:
- Publication type:
- Article
Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. 1137, doi. 10.1002/ajh.26268
- By:
- Publication type:
- Article
Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 1000, doi. 10.1002/ajh.26238
- By:
- Publication type:
- Article
An effective chemotherapy‐free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome‐positive acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. E229, doi. 10.1002/ajh.26175
- By:
- Publication type:
- Article
Haploidentical transplants for patients with relapse after the first allograft.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1187, doi. 10.1002/ajh.25924
- By:
- Publication type:
- Article
Haploidentical transplants for patients with graft failure after the first allograft.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. E267, doi. 10.1002/ajh.25917
- By:
- Publication type:
- Article
Philadelphia chromosome‐positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. 1388, doi. 10.1002/ajh.25648
- By:
- Publication type:
- Article
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. 1382, doi. 10.1002/ajh.25647
- By:
- Publication type:
- Article
Long‐term durable efficacy of autologous stem cell transplantation in POEMS syndrome.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. E72, doi. 10.1002/ajh.25375
- By:
- Publication type:
- Article
Melphalan‐based autologous transplant in octogenarian multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. E2, doi. 10.1002/ajh.25310
- By:
- Publication type:
- Article
Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 91, doi. 10.1002/ajh.24947
- By:
- Publication type:
- Article
Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. 331, doi. 10.1002/ajh.24632
- By:
- Publication type:
- Article
Phase II trial of HyperCVAD and Dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 3, p. 282, doi. 10.1002/ajh.23624
- By:
- Publication type:
- Article
Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilization.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 9, p. 754, doi. 10.1002/ajh.23499
- By:
- Publication type:
- Article
High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 11, p. 954, doi. 10.1002/ajh.22143
- By:
- Publication type:
- Article
Poor hematopoietic stem cell mobilizers: A single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 6, p. 335, doi. 10.1002/ajh.21400
- By:
- Publication type:
- Article
Nonmyeloablative Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia in the Imatinib Era.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S261, doi. 10.3816/CLM.2009.s.021
- By:
- Publication type:
- Article
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11712-6
- By:
- Publication type:
- Article
Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01594
- By:
- Publication type:
- Article
Mesenchymal Stromal Cells: The Magic Band-Aid?
- Published in:
- Acta Haematologica, 2014, v. 133, n. 1, p. 70, doi. 10.1159/000363644
- By:
- Publication type:
- Article
Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults.
- Published in:
- Acta Haematologica, 2014, v. 132, n. 3/4, p. 313, doi. 10.1159/000360211
- By:
- Publication type:
- Article
The impact of pre-transplant valganciclovir on early cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2014, v. 20, n. 4, p. 257, doi. 10.1177/1078155213501360
- By:
- Publication type:
- Article
A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells.
- Published in:
- Biomedical Microdevices, 2010, v. 12, n. 5, p. 855, doi. 10.1007/s10544-010-9440-3
- By:
- Publication type:
- Article
Graft loss attributed to possible transfusion‐transmitted ehrlichiosis following cord blood stem cell transplant.
- Published in:
- Transplant Infectious Disease, 2018, v. 20, n. 4, p. 1, doi. 10.1111/tid.12899
- By:
- Publication type:
- Article
A randomized study comparing chemotherapy followed by G-CS F alone or in combination with GM-CS F for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas.
- Published in:
- Journal of Blood Medicine, 2010, v. 1, p. 49, doi. 10.2147/jbm.s9846
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in Adults: Therapeutic Options and Challenges in 2023.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 11, p. 779, doi. 10.1016/j.clml.2023.06.007
- By:
- Publication type:
- Article
CT-046: Post-Transplant Cyclophosphamide in HLA-Matched and Haploidentical Transplant Recipients Receiving a Myeloablative Fractionated Busulfan Conditioning Regimen: Results of a Phase II Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S446, doi. 10.1016/S2152-2650(21)01992-3
- By:
- Publication type:
- Article
Poster: CT-046: Post-Transplant Cyclophosphamide in HLA-Matched and Haploidentical Transplant Recipients Receiving a Myeloablative Fractionated Busulfan Conditioning Regimen: Results of a Phase II Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S258, doi. 10.1016/S2152-2650(21)01627-X
- By:
- Publication type:
- Article
Current Approach to Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S54, doi. 10.1016/S2152-2650(21)01208-8
- By:
- Publication type:
- Article
Debate: Transplant Is Still Necessary in the Era of Targeted Cellular Therapy for Acute Lymphoblastic Leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Debate: Transplant is Still Necessary in the Era of Targeted Cellular Therapy for ALL.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S55, doi. 10.1016/j.clml.2019.07.418
- By:
- Publication type:
- Article
Reduced-Intensity Chemotherapy Plus Inotuzumab Ozogamicin, With or Without Sequential Blinatumomab, is Highly Effective as First Salvage Treatment in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S186, doi. 10.1016/j.clml.2019.07.026
- By:
- Publication type:
- Article
CAR T-Cell Therapies: Overcoming the Challenges and New Strategies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S74, doi. 10.1016/j.clml.2017.08.038
- By:
- Publication type:
- Article
Management of Important Adverse Events Associated with Inotuzumab Ozogamicin in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S261, doi. 10.1016/j.clml.2017.07.027
- By:
- Publication type:
- Article
A Phase II Trial of Inotuzumab Ozogamicin Combined with Mini-HyperCVD as Salvage Therapy for Relapsed/Refractory ALL.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S264, doi. 10.1016/j.clml.2017.07.032
- By:
- Publication type:
- Article
Utility of Day 14 Bone Marrow Evaluation in Adults with Philadelphia Chromosome-Negative ALL: Relationship with Minimal Residual Disease Status.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S14, doi. 10.1016/j.clml.2016.07.021
- By:
- Publication type:
- Article
Complex Karyotype and Low Hypodiploidy/Near Triploidy are Adverse Prognostic Factors in Adult ALL (ALL) Independent of MRD Status.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S7, doi. 10.1016/j.clml.2016.07.011
- By:
- Publication type:
- Article